Electroconvulsive therapy
Electroconvulsive therapy | |
---|---|
electroencephalography (EEG) in a modern ECT suite | |
Other names | Electroshock therapy |
ICD-10-PCS | GZB |
ICD-9-CM | 94.27 |
MeSH | D004565 |
OPS-301 code | 8-630 |
MedlinePlus | 007474 |
Electroconvulsive therapy (ECT) or electroshock therapy (EST) is a
Aside from effects on the brain, the general physical risks of ECT are similar to those of brief
ECT is often used as an intervention for major depressive disorder, mania, and catatonia.[4] The usual course of ECT involves multiple administrations, typically given two or three times per week until the patient no longer has symptoms. ECT is administered under anesthesia with a muscle relaxant.[7] ECT can differ in its application in three ways: electrode placement, treatment frequency, and the electrical waveform of the stimulus. These treatment parameters can pose significant differences in both adverse side effects and symptom remission in the treated patient.
Placement can be bilateral, where the electric current is passed from one side of the brain to the other, or unilateral, in which the current is solely passed across one
History
As early as the 16th century, agents to induce seizures were used to treat psychiatric conditions. In 1785, the therapeutic use of seizure induction was documented in the
In the second half of the 19th century, such efforts were frequent enough in British asylums as to make it notable.[13]
Convulsive therapy was introduced in 1934 by Hungarian neuropsychiatrist
In 1937, the first international meeting on
The ECT procedure was first conducted in 1938 by Italian neuro-psychiatrist
It was believed early on that inducing convulsions aided in helping those with severe
A positive side effect to the treatment was retrograde amnesia. It was because of this side effect that patients could not remember the treatments and had no ill feelings toward it.[19]
ECT soon replaced metrazol therapy all over the world because it was cheaper, less frightening and more convenient.[20] Cerletti and Bini were nominated for a Nobel Prize but did not receive one. By 1940, the procedure was introduced to both England and the US. In Germany and Austria, it was promoted by Friedrich Meggendorfer. Through the 1940s and 1950s, the use of ECT became widespread. At the time the ECT device was patented and commercialized abroad, the two Italian inventors had competitive tensions that damaged their relationship.[21] In the 1960s, despite a climate of condemnation, the original Cerletti-Bini ECT apparatus prototype was contended by scientific museums between Italy and the US.[22] The ECT apparatus prototype is now owned and displayed by the Sapienza Museum of the History of Medicine in Rome.[22]
In the early 1940s, in an attempt to reduce the memory disturbance and confusion associated with treatment, two modifications were introduced: the use of unilateral electrode placement and the replacement of
In the 1940s and early 1950s, ECT was usually given in an "unmodified" form, without muscle relaxants, and the seizure resulted in a full-scale convulsion. A rare but serious complication of unmodified ECT was fracture or dislocation of the long bones. In the 1940s, psychiatrists began to experiment with
The steady growth of antidepressant use along with negative depictions of ECT in the mass media led to a marked decline in the use of ECT during the 1950s to the 1970s. The Surgeon General stated there were problems with electroshock therapy in the initial years before anesthesia was routinely given, and that "these now-antiquated practices contributed to the negative portrayal of ECT in the popular media."[24] The New York Times described the public's negative perception of ECT as being caused mainly by one movie: "For Big Nurse in One Flew Over the Cuckoo's Nest, it was a tool of terror, and, in the public mind, shock therapy has retained the tarnished image given it by Ken Kesey's novel: dangerous, inhumane and overused".[25]
In 1976, Dr. Blatchley demonstrated the effectiveness of his constant current, brief pulse device ECT. This device eventually largely replaced earlier devices because of the reduction in cognitive side effects, although as of 2012 some ECT clinics still were using sine-wave devices.[26]
The 1970s saw the publication of the first American Psychiatric Association (APA) task force report on electroconvulsive therapy (to be followed by further reports in 1990 and 2001). The report endorsed the use of ECT in the treatment of depression. The decade also saw criticism of ECT.[27] Specifically, critics pointed to shortcomings such as noted side effects, the procedure being used as a form of abuse, and uneven application of ECT. The use of ECT declined until the 1980s, "when use began to increase amid growing awareness of its benefits and cost-effectiveness for treating severe depression".[24] In 1985, the National Institute of Mental Health and National Institutes of Health convened a consensus development conference on ECT and concluded that, while ECT was the most controversial treatment in psychiatry and had significant side-effects, it had been shown to be effective for a narrow range of severe psychiatric disorders.[28]
Because of the backlash noted previously, national institutions reviewed past practices and set new standards. In 1978, the American Psychiatric Association released its first task force report in which new standards for
Though ECT use declined with the advent of modern antidepressants, there has been a resurgence of ECT with new modern technologies and techniques.[30] Modern shock voltage is given for a shorter duration of 0.5 milliseconds where conventional brief pulse is 1.5 milliseconds.[31]
In a review from 2022 of neuroimaging studies based on a global data collaboration ECT was suggested to work via a temporary disruption of neural circuits followed by augmented neuroplasticity and rewiring.[32]
Modern use
ECT is used, where possible, with
Major depressive disorder
For
Efficacy
A
In 2004, a meta-analytic review paper found in terms of efficacy, "a significant superiority of ECT in all comparisons: ECT versus simulated ECT, ECT versus placebo, ECT versus antidepressants in general, ECT versus tricyclics and ECT versus monoamine oxidase inhibitors."[43]
In 2003, The UK ECT Review Group published a systematic review and meta-analysis comparing ECT to placebo and antidepressant drugs. This meta-analysis demonstrated a large effect size (high efficacy relative to the mean in terms of the standard deviation) for ECT versus placebo, and versus antidepressant drugs.[44]
Compared with
The response rate is from 50 to 70% in treatment-resistant patients.[46] Efficacy does not depend on depression subtype.[37]
Follow-up
There is little agreement on the most appropriate follow-up to ECT for people with major depressive disorder.
Lithium has also been found to reduce the risk of relapse, especially in younger patients.[48]
Catatonia
ECT is generally a second-line treatment for people with
Mania
ECT is used to treat people who have severe or prolonged
Schizophrenia
ECT is widely used worldwide in the treatment of
Effects
Aside from effects in the brain, the general physical risks of ECT are similar to those of brief
While there are no absolute contraindications for ECT, there is increased risk for patients who have unstable or severe cardiovascular conditions or
In adolescents, ECT is highly efficient for several psychiatric disorders, with few and relatively benign adverse effects.[59][60][61]
Risk of death
A meta-analysis from 2017 found that the death rate of ECT was around 2.1 per 100,000 procedures.[62] A review from 2011 reported an estimate of the mortality rate associated with ECT as less than 1 death per 73,440 treatments.[63]
Cognitive impairment
Cognitive impairment is sometimes noticed after ECT.
The acute effects of ECT can include amnesia, both retrograde (for events occurring before the treatment) and anterograde (for events occurring after the treatment).[70] Memory loss and confusion are more pronounced with bilateral electrode placement rather than unilateral, and with outdated sine-wave rather than brief-pulse currents. The use of either constant or pulsing electrical impulses also varied the memory loss results in patients. Patients who received pulsing electrical impulses, as opposed to a steady flow, seemed to incur less memory loss. The vast majority of modern treatment uses brief pulse currents.[70]
Retrograde amnesia is most marked for events occurring in the weeks or months before treatment, with one study showing that although some people lose memories from years prior to treatment, recovery of such memories was "virtually complete" by seven months post-treatment, with the only enduring loss being memories in the weeks and months prior to the treatment.[71][72] Anterograde memory loss is usually limited to the time of treatment itself or shortly afterwards. In the weeks and months following ECT these memory problems gradually improve, but some people have persistent losses, especially with bilateral ECT.[1][70] One published review summarizing the results of questionnaires about subjective memory loss found that between 29% and 55% of respondents believed they experienced long-lasting or permanent memory changes.[73] In 2000, American psychiatrist Sarah Lisanby and colleagues found that bilateral ECT left patients with more persistently impaired memory of public events as compared to right unilateral ECT.[68]
Effects on brain structure
Considerable controversy exists over the effects of ECT on brain tissue, although a number of mental health associations—including the APA—have concluded that there is no evidence that ECT causes structural brain damage.[5][40] A 1999 report by the US Surgeon General states: "The fears that ECT causes gross structural brain pathology have not been supported by decades of methodologically sound research in both humans and animals."[74]
Many expert proponents of ECT maintain that the procedure is safe and does not cause brain damage. Dr. Charles Kellner, a prominent ECT researcher and former chief editor of the Journal of ECT, stated in a 2007 interview that, "There are a number of well-designed studies that show ECT does not cause brain damage and numerous reports of patients who have received a large number of treatments over their lifetime and have suffered no significant problems due to ECT."[75] Kellner cites a study purporting to show an absence of cognitive impairment in eight subjects after more than 100 lifetime ECT treatments.[76] Kellner stated "Rather than cause brain damage, there is evidence that ECT may reverse some of the damaging effects of serious psychiatric illness." Two meta-analyses find that ECT is associated with brain matter growth.[77][78]
Effects in pregnancy
If steps are taken to decrease potential risks, ECT is generally accepted to be relatively safe during all trimesters of pregnancy, particularly when compared to pharmacological treatments.[6][79] Suggested preparation for ECT during pregnancy includes a pelvic examination, discontinuation of nonessential anticholinergic medication, uterine tocodynamometry, intravenous hydration, and administration of a nonparticulate antacid. During ECT, elevation of the pregnant woman's right hip, external fetal cardiac monitoring, intubation, and avoidance of excessive hyperventilation are recommended.[6] In many instances of active mood disorder during pregnancy, the risks of untreated symptoms may outweigh the risks of ECT. Potential complications of ECT during pregnancy can be minimized by modifications in technique. The use of ECT during pregnancy requires thorough evaluation of the patient's capacity for informed consent.[80]
Effects on the heart
ECT can cause a lack of blood flow and oxygen to the heart,
Procedure
The placement of electrodes, as well as the dose and duration of the stimulation is determined on a per-patient basis.[1]: 1881
In unilateral ECT, both electrodes are placed on the same side of the patient's head. Unilateral ECT may be used first to minimize side effects such as memory loss.
In bilateral ECT, the two electrodes are placed on opposite sides of the head. Usually bitemporal placement is used, whereby the electrodes are placed on the temples. Uncommonly bifrontal placement is used; this involves positioning the electrodes on the patient's forehead, roughly above each eye.
Unilateral ECT is thought to cause fewer cognitive effects than bilateral treatment, but is less effective unless administered at higher doses.[1]: 1881 Most patients in the US[84] and almost all in the UK[85][86][87] receive bilateral ECT.
The electrodes deliver an electrical stimulus. The stimulus levels recommended for ECT are in excess of an individual's seizure threshold: about one and a half times seizure threshold for bilateral ECT and up to 12 times for unilateral ECT.
Immediately prior to treatment, a patient is given a short-acting anesthetic such as
The patient's
ECT is usually administered three times a week, on alternate days, over a course of two to four weeks.[1]: 1882–1883
Neuroimaging prior to ECT
Neuroimaging prior to ECT may be useful for detecting intracranial pressure or mass given that patients respond less when one of these conditions exist. Nonetheless, it is not indicated due to high cost and low prevalence of these conditions in patients needing ECT.[95]
Concurrent pharmacotherapy
Whether psychiatric medications are terminated prior to treatment or maintained, varies.
A 2009 RCT provides some evidence indicating that concurrent use of some antidepressant improves ECT efficacy.[37]
Course
ECT is usually done from 6 to 12 times in 2 to 4 weeks but can sometimes exceed 12 rounds.[37] It is also recommended to not do ECT more than 3 times per week.[37]
Treatment team
In the US, the medical team performing the procedure typically consists of a psychiatrist, an anesthetist, an ECT treatment nurse or qualified assistant, and one or more recovery nurses.[5]: 109 Medical trainees may assist, but only under the direct supervision of credentialed attending physicians and staff.[5]: 110
Devices
Most modern ECT devices deliver a brief-pulse current, which is thought to cause fewer cognitive effects than the sine-wave currents which were originally used in ECT.[1] A small minority of psychiatrists in the US still use sine-wave stimuli.[84] Sine-wave is no longer used in the UK or Ireland.[87] Typically, the electrical stimulus used in ECT is about 800
In the US, ECT devices are manufactured by two companies, Somatics, which is owned by psychiatrists Richard Abrams and Conrad Swartz, and Mecta.[98] In the UK, the market for ECT devices was long monopolized by Ectron Ltd, which was set up by psychiatrist Robert Russell.[99]
Mechanism of action
Despite decades of research, the exact mechanism of action of ECT remains elusive. A review from 2022 of neuroimaging studies based on a global data collaboration resulted in a model of temporary disruption of neural circuits followed by augmented neuroplasticity and rewiring.[32]
Use
As of 2001, it was estimated that about one million people received ECT annually.[26]
There is wide variation in ECT use between different countries, different hospitals, and different psychiatrists.[1][26] International practice varies considerably from widespread use of the therapy in many Western countries to a small minority of countries that do not use ECT at all, such as Slovenia.[100]
About 70 percent of ECT patients are women.[1] This may be because women are more likely to be diagnosed with depression.[1][101] Older and more affluent patients are also more likely to receive ECT. The use of ECT is not as common in ethnic minorities.[101][102]
In Sweden, which has a complete register of all ECT treatments in the country, in 2013 the rate of persons treated in that year per 100,000 inhabitants was 41. Almost the same rate had already been present in 1975 with 42 patients per 100,000 inhabitants.[103][104]
United States
ECT became popular in the US in the 1940s. At the time, psychiatric hospitals were overrun with patients whom doctors were desperate to treat and cure. Whereas
Accurate statistics about the frequency, context and circumstances of ECT in the US are difficult to obtain because only a few states have reporting laws that require the treating facility to supply state authorities with this information.[106] In 13 of the 50 states, the practice of ECT is regulated by law.[107]
In the mid-1990s in Texas, ECT was used in about one third of psychiatric facilities and given to about 1,650 people annually.[101] Usage of ECT has since declined slightly; in 2000–01 ECT was given to about 1,500 people aged from 16 to 97 (in Texas it is illegal to give ECT to anyone under sixteen).[108] ECT is more commonly used in private psychiatric hospitals than in public hospitals, and minority patients are underrepresented in the ECT statistics.[1]
In the United States, ECT is usually given three times a week; in the United Kingdom, it is usually given twice a week.[1] Occasionally it is given on a daily basis.[1] A course usually consists of 6–12 treatments, but may be more or fewer. Following a course of ECT some patients may be given continuation or maintenance ECT with further treatments at weekly, fortnightly or monthly intervals.[1] A few psychiatrists in the US use multiple-monitored ECT (MMECT), where patients receive more than one treatment per anesthetic.[1] Electroconvulsive therapy is not a required subject in US medical schools and not a required skill in psychiatric residency training. Privileging for ECT practice at institutions is a local option: no national certification standards are established, and no ECT-specific continuing training experiences are required of ECT practitioners.[109]
United Kingdom
In the UK in 1980, an estimated 50,000 people received ECT annually, with use declining steadily since then[110] to about 12,000 per annum in 2002.[111] It is still used in nearly all psychiatric hospitals, with a survey of ECT use from 2002 finding that 71 percent of patients were women and 46 percent were over 65 years of age. Eighty-one percent had a diagnosis of mood disorder; schizophrenia was the next most common diagnosis. Sixteen percent were treated without their consent.[111] In 2003, the National Institute for Health and Care Excellence, a government body which was set up to standardize treatment throughout the National Health Service in England and Wales, issued guidance on the use of ECT. Its use was recommended "only to achieve rapid and short-term improvement of severe symptoms after an adequate trial of treatment options has proven ineffective and/or when the condition is considered to be potentially life-threatening in individuals with severe depressive illness, catatonia or a prolonged manic episode".[112]
The guidance received a mixed reception. It was welcomed by an editorial in the British Medical Journal[113] but the Royal College of Psychiatrists launched an unsuccessful appeal.[114] The NICE guidance, as the British Medical Journal editorial points out, is only a policy statement and psychiatrists may deviate from it if they see fit. Adherence to standards has not been universal in the past. A survey of ECT use in 1980 found that more than half of ECT clinics failed to meet minimum standards set by the Royal College of Psychiatrists, with a later survey in 1998 finding that minimum standards were largely adhered to, but that two-thirds of clinics still fell short of current guidelines, particularly in the training and supervision of junior doctors involved in the procedure.[115] A voluntary accreditation scheme, ECTAS, was set up in 2004 by the Royal College, and as of 2017[update] the vast majority of ECT clinics in England, Wales, Northern Ireland and the Republic of Ireland have signed up.[116]
The Mental Health Act 2007 allows people to be treated against their will. This law has extra protections regarding ECT. A patient capable of making the decision can decline the treatment, and in that case treatment cannot be given unless it will save that patient's life or is immediately necessary to prevent deterioration of the patient's condition. A patient may not be capable of making the decision (they "lack capacity"), and in that situation ECT can be given if it is appropriate and also if there are no advance directives that prevent the use of ECT.[117]
China
ECT was introduced in China in the early 1950s and while it was originally practiced without anesthesia, as of 2012 almost all procedures were conducted with it. As of 2012, there are approximately 400 ECT machines in China, and 150,000 ECT treatments are performed each year.[118] Chinese national practice guidelines recommend ECT for the treatment of schizophrenia, depressive disorders, and bipolar disorder and in the Chinese literature, ECT is an effective treatment for schizophrenia and mood disorders.[118]
Although the Chinese government stopped classifying homosexuality as an illness in 2001, electroconvulsive therapy is still used by some establishments as a form of "conversion therapy".[119][120] Alleged Internet addiction (or general unruliness) in adolescents is also known to have been treated with ECT, sometimes without anestheia, most notably by Yang Yongxin. The practice was banned in 2009 after news on Yang broke out.[121]
Society and culture
Controversy
Surveys of public opinion, the testimony of former patients, legal restrictions on the use of ECT and disputes as to the efficacy, ethics and adverse effects of ECT within the psychiatric and wider medical community indicate that the use of ECT remains controversial.[122][123][124][125][126][127][128] This is reflected in the January 2011 vote by the FDA's Neurological Devices Advisory Panel to recommend that FDA maintain ECT devices in the Class III device category for high risk devices, except for patients with catatonia, major depressive disorder, and bipolar disorder.[129] This may result in the manufacturers of such devices having to do controlled trials on their safety and efficacy for the first time.[4][130][131] In justifying their position, panelists referred to the memory loss associated with ECT and the lack of long-term data.[132]
Legal status
Informed consent
The World Health Organization (2005) advises that ECT should be used only with the informed consent of the patient (or their guardian if their incapacity to consent has been established).[34]
In the US, this doctrine places a legal obligation on a doctor to make a patient aware of the reason for treatment, the risks and benefits of a proposed treatment, the risks and benefits of alternative treatment, and the risks and benefits of receiving no treatment. The patient is then given the opportunity to accept or reject the treatment. The form states how many treatments are recommended and also makes the patient aware that consent may be revoked and treatment discontinued at any time during a course of ECT.[3] The US Surgeon General's Report on Mental Health states that patients should be warned that the benefits of ECT are short-lived without active continuation treatment in the form of drugs or further ECT, and that there may be some risk of permanent, severe memory loss after ECT.[3] The report advises psychiatrists to involve patients in discussion, possibly with the aid of leaflets or videos, both before and during a course of ECT.
According to the US Surgeon General, involuntary treatment is uncommon in the US and is typically used only in cases of great extremity, and only when all other treatment options have been exhausted. The use of ECT is believed to be a potentially life-saving treatment.[74]
In one of the few jurisdictions where recent statistics on ECT usage are available, a national audit of ECT by the Scottish ECT Accreditation Network indicated that 77% of patients who received the treatment in 2008 were capable of giving informed consent.[133]
In the UK, in order for consent to be valid it requires an explanation in "broad terms" of the nature of the procedure and its likely effects.[134] One review from 2005 found that only about half of patients felt they were given sufficient information about ECT and its adverse effects[135] and another survey found that about fifty percent of psychiatrists and nurses agreed with them.[136]
A 2005 study published in the British Journal of Psychiatry described patients' perspectives on the adequacy of informed consent before ECT.[135] The study found that "About half (45–55%) of patients reported they were given an adequate explanation of ECT, implying a similar percentage felt they were not." The authors also stated:
Approximately a third did not feel they had freely consented to ECT even when they had signed a consent form. The proportion who feel they did not freely choose the treatment has actually increased over time. The same themes arise whether the patient had received treatment a year ago or 30 years ago. Neither current nor proposed safeguards for patients are sufficient to ensure informed consent with respect to ECT, at least in England and Wales.[135]
Involuntary ECT
Procedures for involuntary ECT vary from country to country depending on local mental health laws.
United States
In most states in the US, a judicial order following a formal hearing is needed before a patient can be forced to undergo involuntary ECT.[3] However, ECT can also be involuntarily administered in situations with less immediate danger. Suicidal intent is a common justification for its involuntary use, especially when other treatments are ineffective.[3]
United Kingdom
Until 2007 in England and Wales, the
Regulation
In the US, ECT devices came into existence prior to medical devices being regulated by the
By country
Australia
In Western Australia, ECT has been heavily restricted since 2014, after a bill passed with bipartisan support introducing restrictions on ECT, which were welcomed by mental health experts. Children under 14 are prohibited from receiving ECT, while those aged 14 to 18 must have informed consent approval from the Mental Health Tribunal. The law imposes a $15,000 fine on anyone who performs ECT on a child under the age of 14.[144]
Similarly, ECT is also banned on children under the age of 12 in the Australian Capital Territory (ACT).[145]
United States
Many mental health facilities offer ECT for specific diagnoses, such as
Judge Rotenberg Center
In 2020 the Food and Drug Administration (FDA) implemented a rule previously drafted in 2016 banning the use of ECT to treat disabilities. This ban specifically had major complications for the controversial Judge Rotenberg Center (JRC) in Canton, Massachusetts, which uses various methods of ECT. Specifically, it is believed by many that most of the cases at JRC do not require the use of ECT.[148][149][150]
Public perception
A questionnaire survey of 379 members of the general public in
Famous cases
- Ernest Hemingway, an American author, died by suicide in 1961 half a year after ECT treatment at the Mayo Clinic in 1960.[152] He is reported to have said to his biographer, "Well, what is the sense of ruining my head and erasing my memory, which is my capital, and putting me out of business? It was a brilliant cure but we lost the patient."[153] However, the same biographer (Hotchner, 1966) and also a second biographer (Lynn, 1987) emphasized - according to a review from 2008 - "that Hemingway’s serious mental illness and plans for suicide significantly predated his ECT treatments."[154]
- Robert Pirsig had a nervous breakdown and spent time in and out of psychiatric hospitals between 1961 and 1963.[155] He was diagnosed with paranoid schizophrenia and clinical depression as a result of an evaluation conducted by psychoanalysts, and was treated with electroconvulsive therapy on numerous occasions,[156] a treatment he discusses in his novel, Zen and the Art of Motorcycle Maintenance.[157]
- 1972 United States Presidential Election as the party's vice presidential candidate after it was revealed that he had received electroshock treatment in the past for depression.[158] Presidential nominee George McGovern replaced him with Sargent Shriver, and later went on to lose by a landslide to Richard Nixon.
- American surgeon and award-winning author Sherwin B. Nuland is another notable person who has undergone ECT.[159] In his 40s, his depression became so severe that he had to be institutionalized. After exhausting all treatment options, a young resident assigned to his case suggested ECT, which ended up being successful.[160]
- Author David Foster Wallace also received ECT for many years, beginning as a teenager, before his suicide at age 46.[161]
- New Zealand author Janet Frame experienced both insulin coma therapy and ECT (but without the use of anesthesia or muscle relaxants).[162] She wrote about this in her autobiography, An Angel at My Table (1984),[162] which was later adapted into a film (1990).[163]
- American actor Carrie Fisher wrote about her experience with memory loss after ECT treatments in her memoir Wishful Drinking.[164]
- Lou Reed had ECT as a teenager to "cure" his homosexuality.[165] He later claimed it had induced multiple personality disorder, and resulted in his hatred of psychiatrists.[166] After Reed's death, his sister denied the ECT treatments were intended to suppress his "homosexual urges", asserting that their parents were not homophobic but had been told by his doctors that ECT was necessary to treat Reed's mental and behavioral issues.[165]
Fictional examples
Electroconvulsive therapy has been depicted in fiction, including fictional works partly based on true experiences. These include Sylvia Plath's semi-autobiographical novel, The Bell Jar, Ken Loach's film Family Life, and Ken Kesey's novel One Flew Over the Cuckoo's Nest; Kesey's novel is a direct product of his time working the graveyard shift as an orderly at a mental health facility in Menlo Park, California.[167][168]
Two analyses of large numbers of films using ECT scenes found that almost all presented fictional settings that were unrelated to real treatment routines and were apparently aimed at stigmatizing ECT as a tool of repression and of mind and behavior control - having effects of memory-erosion, pain and damage.[169][170]
The song “The Mind Electric” by
See also
References
- ^ a b c d e f g h i j k l m n o p q r s t u Rudorfer MV, Henry ME, Sackeim HA (2003). "Electroconvulsive therapy" (PDF). In Tasman A, Kay J, Lieberman JA (eds.). Psychiatry (Second ed.). Chichester: John Wiley & Sons Ltd. pp. 1865–1901. Archived (PDF) from the original on 2007-08-10.
- ^ Solano J (2009-04-20). "Electroconvulsive Therapy" (PDF). p. 4. Archived (PDF) from the original on 2022-02-18. Retrieved 2022-05-17.
- ^ a b c d e f Surgeon General (1999). Mental Health: A Report of the Surgeon General, chapter 4.
- ^ a b c d e f g h i FDA. FDA Executive Summary. Prepared for the January 27–28, 2011 meeting of the Neurological Devices Panel Meeting to Discuss the Classification of Electroconvulsive Therapy Devices (ECT). Quote, p. 38: "Three major practice guidelines have been published on ECT. These guidelines include: APA Task Force on ECT (2001); Third report of the Royal College of Psychiatrists' Special Committee on ECT (2004); National Institute for Health and Clinical Excellence (NICE 2003; NICE 2009). There is significant agreement between the three sets of recommendations."
- ^ ISBN 978-0-89042-206-9.
- ^ S2CID 31209001.
- ^ Margarita Tartakovsky (2012) Psych Central. 5 Outdated Beliefs About ECT Archived 2013-08-08 at the Wayback Machine
- (PDF) from the original on 2021-06-16.
- ^ A History of Mental Institutions in the United States which says electrostatic machines were used in 1773
- ^ "Lind, James (1736–1812) on JSTOR". plants.jstor.org. Retrieved 2021-05-08.
- PMID 15595271.
- ^ Wright BA. "An Historical Review of Electro Convulsive Therapy". Jefferson Journal of Psychiatry: 66–74.
- S2CID 31015334. Archived from the original(PDF) on 23 September 2015. Retrieved 28 December 2014.
- S2CID 12121233.
- ^ PMID 6147103.
- PMID 21324238.
- ISBN 3927408824
- ^ Rudorfer MV, Henry ME, Sackheim HA (1997). "Electroconvulsive therapy". In Tasman A, Lieberman JA (eds.). Psychiatry. pp. 1535–1556.
- ^ a b Sabbatini R. "The history of shock therapy in psychiatry". Retrieved 2013-04-24.
- ^ Cerletti, U (1956). "Electroshock therapy". In AM Sackler et al. (eds) The Great Physiodynamic Therapies in Psychiatry: an historical appraisal. New York: Hoeber-Harper, 91–120.
- S2CID 218991982.
- ^ a b Sirgiovanni, E, Aruta, A (2020) "The Electroshock Triangle: Disputes about the ECT Apparatus Prototype and its Display in the 1960s, History of Psychiatry. First Published April 20, 2020: https://doi.org/10.1177/0957154X20916147.
- ^ ISBN 0867931124
- ^ a b Goode E (1999-10-06). "Federal Report Praising Electroshock Stirs Uproar". The New York Times. Retrieved 2008-01-01.
- ^ Goleman D (1990-08-02). "The Quiet Comeback of Electroshock Therapy". The New York Times. p. B5. Retrieved 2008-01-01.
- ^ PMID 22741102.
- ^ See:
- Friedberg J (September 1977). "Shock treatment, brain damage, and memory loss: a neurological perspective". The American Journal of Psychiatry. 134 (9). American Psychiatric Association Publishing: 1010–1014. PMID 900284.
- Breggin PR (1979). Electroshock: its brain-disabling effects. New York: Springer. OCLC 5029460.
- Friedberg J (September 1977). "Shock treatment, brain damage, and memory loss: a neurological perspective". The American Journal of Psychiatry. 134 (9). American Psychiatric Association Publishing: 1010–1014.
- PMID 3774937.
- ^ Dutton A (2017-02-18). "This mental health treatment isn't barbaric, it 'totally changed my life'".
- ^ "Electroconvulsive therapy: How modern techniques improve patient outcomes".
- .
- ^ PMID 34274106.
- S2CID 36643014.
- ^ a b World Health Organisation (2005). WHO Resource Book on Mental Health, Human Rights and Legislation Archived 2006-12-06 at the Wayback Machine. Geneva, 64.
- S2CID 218586379.
- PMID 23897945.
- ^ ISBN 978-1-118-75337-8.
- PMID 15791182.
- S2CID 204073048.
- ^ National Institute for Clinical Excellence. 2009.
- ISBN 978-1-4377-0434-1.
- S2CID 44280002.
- S2CID 25843283.
- S2CID 28964580.
- PMID 25143831.
- PMID 36082600.
- ^ PMID 23774532.
- S2CID 231759831.
- ^ PMID 25538636.
- S2CID 4013882.
- S2CID 22002956.
- ^ a b NICE Guidance on the use of electroconvulsive therapy. NICE technology appraisals TA59. Published date: April 2003
- S2CID 2058163.
- S2CID 37771648.
- PMID 15846598.
- S2CID 207428569.
- S2CID 45842375.
- S2CID 6423840.
- ISBN 978-0199937899, pp. 161–280.
- PMID 23718899.
- S2CID 207934946.
- S2CID 31879446.
- S2CID 33442075.
- PMID 21131410.
- PMID 24820942.
- PMID 25522389.
- PMID 20194546.
- ^ PMID 10839336.
- S2CID 45019739.
- ^ a b c Benbow, SM (2004) "Adverse effects of ECT". In AIF Scott (ed.) The ECT Handbook, second edition. Archived 2012-04-21 at the Wayback Machine London: The Royal College of Psychiatrists, pp. 170–174.
- PMID 7458573.
- S2CID 22600323.
- PMID 12816822.
- ^ a b "Chapter 4". Mental Health: A Report of the Surgeon General (Report). Office of the Surgeon General (US). Retrieved 2007-12-29.
- ^ Sussman N (March 2007). "In Session with Charles H. Kellner, MD: Current Developments in Electroconvulsive Therapy". Primary Psychiatry. 14 (3): 34–37. Archived from the original on 2011-05-16. Retrieved 2009-10-17.
- PMID 2053635.
- S2CID 14042369.
- PMID 28989984.
- S2CID 24489076.
- PMID 8045538.
- ^ PMID 30557212.
- S2CID 246442707.
- ISSN 1559-4343.
- ^ S2CID 12210381.
- ^ Barnes R. "Information on ECT". Royal College of Psychiatrists' Special Committee on ECT and related treatment. Retrieved 3 November 2013.
- ISBN 978-1904671220
- ^ S2CID 23584054.
- ^ a b Lock, T (1995). "Stimulus dosing". In C Freeman (ed.) The ECT Handbook. London: Royal College of Psychiatrists, 72–87.
- S2CID 41654261.
- S2CID 5985564.
- PMID 10734527.
- ^ Teena Thacker for Indian Express. Mar 23 2011 Electroshocks for mentally ill patients to be banned
- PMID 24082240.
- ^ "Abusive practice of "unmodified" electroshock treatment abolished at main psychiatric facility of Turkey". Disabled Peoples' International. Archived from the original on 2007-10-12. Retrieved 2008-03-25.
- S2CID 49432743.
- PMID 20805728.
- ^ Madhavan Seshadri, Nadeem Z Mazi-Kotwal. "Response Predictors in ECT: A discussion about Seizure Threshold". British Journal of Medical Practitioners. Retrieved 23 March 2016.
- ^ Corinne Slusher for MedScape. Updated: Jan 6, 2012 Electroconvulsive Therapy Machine
- ^ "Ectron: Our story". Archived from the original on 2014-10-27. Retrieved 2015-01-07.
- ^ See the Slovenian government website Archived 2007-08-08 at the Wayback Machine for information about ECT in Slovenia.
- ^ PMID 9491059.
- S2CID 28261416.
- PMID 25973769.
- PMID 27093104.
- PMID 7755116.
- ^ Cauchon D (1995-12-06). "Patients often aren't informed of full danger". USA Today. Archived from the original on 2008-01-15. Retrieved 2008-01-01.
- ^ "Electroconvulsive Therapy in Children | Psychology Today". www.psychologytoday.com.
- ^ Texas Department of State (2002) Electroconvulsive therapy reports Archived 2007-08-10 at the Wayback Machine.
- ^ Fink, M. & Taylor, A.M. (2007) "Electroconvulsive therapy: Evidence and Challenges" JAMA Vol. 298 No. 3, pp. 330–332.
- S2CID 30499609.
- ^ a b Electro convulsive therapy: survey covering the period from January 2002 to March 2002. Department of Health.
- ^ NICE 2003. Electroconvulsive therapy (ECT) Archived 2008-09-08 at the Wayback Machine. Retrieved on 2007-12-29.
- PMID 12816798.
- ^ NICE (2003). Appraisal of electroconvulsive therapy: decision of the appeal panel Archived 2007-05-21 at the Wayback Machine. London: NICE.
- S2CID 23584054.
- ^ Royal College of Psychiatrists (2017). [1] 2016–2017.
- ^ "Additional safeguards for ECT introduced in new s58A – Mental Health Law Online".
- ^ S2CID 2743272.
- ^ Graham-Harrison E, Connaire S (8 October 2015). "Chinese hospitals still offering gay 'cure' therapy, film reveals". The Guardian.
- ^ Hannah Beech (June 13, 2016). "This Man Was Sectioned in China for Being Gay. Now He's Fighting Back". Time. Retrieved October 20, 2017.
- PMID 19556477.
- S2CID 42581352.
- S2CID 24740314.
- ISBN 978-0-465-02014-0.
- S2CID 6300979.
- ^ Committee on Mental Health (March 2002). "Report on Electroconvulsive Therapy". New York State Assembly. Archived from the original on 30 April 2011. Retrieved 8 March 2011.
- PMID 16862197. Archived from the originalon 2011-05-01. Retrieved 2011-03-08.
- ^ S2CID 40147979.
- ^ a b US Food and Drug Administration (2018-12-21). "FDA In Brief: FDA takes action to ensure regulation of electroconvulsive therapy devices better protects patients, reflects current understanding of safety and effectiveness" (Press release).
- ^ Kellner CH (2012-07-05). "The FDA Advisory Panel on the Reclassification of ECT Devices: Unjustified Ambivalence". Psychiatric Times. UBM Medica. Archived from the original on 2012-08-21. Retrieved 2012-10-25.
- ^ Duff Wilson for the New York Times. January 28, 2011 F.D.A. Panel Is Split on Electroshock Risks
- ^ Mechcatie E. "FDA Regulation of ECT Devices in Transition". Clinical Psychiatry News. Retrieved 8 March 2011.
- ^ Fergusson G, et al., eds. (2009). "The Scottish ECT Accreditation Network (SEÁN) Annual Report 2009" (PDF). Scottish ECT Accreditation Network. Archived (PDF) from the original on 2011-04-29. Retrieved 2010-05-24.
- ^ Jones, R (1996) Mental Health Act Manual, 5th edition. London: Sweet and Maxwell, p. 225.
- ^ a b c Rose D, Wykes T, Bindman J, Fleischmann P (2005)"Information, consent and perceived coercion: patients' perspectives on electroconvulsive therapy". British Journal of Psychiatry 186:54–59.
- S2CID 218906587.
- ^ The Mental Health Act 1983 (updated version) Archived December 26, 2011, at the Wayback Machine Part IV, Section 58. Care Quality Commission
- ^ Care Quality Commission (2010) ECT: Your rights about consent to treatment
- ^ The Mental Health Act 1983 (updated version) Part IV, Section 62. Care Quality Commission
- ^ The Mental Health Act Commission (2005) In Place of Fear? eleventh biennial report, 2003–2005, 236. The Stationery Office.
- ^ "CQC says care for people treated under the Mental Health Act still needs to improve". Care Quality Commission. 8 December 2011. Archived from the original on 21 May 2015.
- ^ The Mental Health (Care and Treatment) (Scotland) Act 2003, Part 16, sections 237–239.
- ^ Levin S, Binder R. "Time Is Now to Support the ECT Reclassification Effort". American Psychiatric Association. Retrieved 23 April 2017.
- ^ "Electroshock therapy on under-14s banned in WA after law passes". ABC News. 17 October 2014.
- ^ "Brutal Rise in Electroshock". 4 December 2017.
- ^ "Electroconvulsive Therapy (ECT) Service | Treatment at McLean Hospital". www.mcleanhospital.org.
- ^ "Electroconvulsive Therapy (ECT)". Mental Health America.
- ^ "#StopTheShock: The Judge Rotenberg Center, Torture, and How We can Stop It - Autistic Self Advocacy Network". 25 June 2020.
- ^ "US Report and Urgent Appeal" (PDF). Archived from the original (PDF) on 2013-01-08. Retrieved 25 February 2024.
- ^ "UN Calls Shock Treatment at Mass. School 'Torture'". ABC News.
- ^ S2CID 11334694.
- ISBN 978-0-333-42126-0.
- ISBN 0786705922; p. 280
- PMID 18196545.
- ^ "All About Heaven \e". allaboutheaven.org. Retrieved 2019-12-30.
- ISBN 978-1-5040-4641-1.
- PMID 19201545.
- ^ "50 years ago: Sen.Thomas Eagleton discloses electric shock treatments and changes a presidential campaign". STLtoday.com. Retrieved 2023-02-27.
- ^ "Sherwin Nuland: How electroshock therapy changed me | Talk Subtitles and Transcript". TED.com. 30 October 2007. Retrieved 2015-05-19.
- ^ Gellene D (2014-03-04). "Sherwin B. Nuland, Author of 'How We Die,' is Dead at 83". The New York Times.
- ^ Lipsky, Dave (October 30, 2008). "The Lost Years & Last Days of David Foster Wallace". Rolling Stone. Archived from the original on May 3, 2009. Retrieved June 5, 2017.
- ^ S2CID 93000402.
- ^ "Review/Film; 3 Novels Are Adapted For 'Angel at My Table'". The New York Times. 21 May 1991. Section C, p. 15. Retrieved 10 July 2020.
- ^ "Wishful Drinking with Carrie Fisher". NPR.
- ^ a b Weiner J (2016-04-10). "Lou Reed's Sister Sets the Record Straight About His Childhood". Cuepoint. Retrieved 2023-08-17.
- ISBN 978-0-8021-4264-1.
- )
- ISBN 978-0-472-06748-0.
- S2CID 206356310.
- S2CID 206144447.
- ^ "Electroconvulsive Therapy Is Torture". TV Tropes. 2024-03-16. Retrieved 2024-03-16.
External links
- Position Statement on Electroconvulsive Therapy (ECT) 2015 – from the American Psychiatric Association.
- ECT – information from mental health charity The Royal College of Psychiatrists